SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

CATTABRIGA, Elena
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.777
EU - Europa 747
AS - Asia 515
OC - Oceania 1
SA - Sud America 1
Totale 4.041
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.775
CN - Cina 349
UA - Ucraina 226
DE - Germania 217
TR - Turchia 149
GB - Regno Unito 87
SE - Svezia 65
IT - Italia 48
FI - Finlandia 45
RU - Federazione Russa 26
NL - Olanda 13
FR - Francia 12
HK - Hong Kong 8
BE - Belgio 5
IN - India 4
CA - Canada 2
AU - Australia 1
BD - Bangladesh 1
BO - Bolivia 1
CZ - Repubblica Ceca 1
IE - Irlanda 1
IM - Isola di Man 1
IQ - Iraq 1
SG - Singapore 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 4.041
Salva come PNG Salva come JPEG
Città #
Woodbridge 346
Fairfield 315
Houston 271
Chandler 270
Jacksonville 247
Ann Arbor 210
Ashburn 159
Seattle 127
Wilmington 105
Nanjing 95
Cambridge 92
Beijing 75
Izmir 71
Princeton 56
Bremen 47
New York 43
Boardman 42
Milan 32
Dearborn 30
Addison 26
Shanghai 26
San Diego 22
Nanchang 19
Shenyang 18
Hebei 17
Tianjin 15
San Mateo 14
Changsha 11
Jinan 11
Auburn Hills 10
Jiaxing 9
Kunming 9
Meppel 9
Norwalk 9
Hong Kong 8
Ningbo 8
Philadelphia 8
Los Angeles 7
Lanzhou 6
Brussels 5
Des Moines 5
Hefei 5
Mountain View 5
Orange 5
Redmond 5
Zhengzhou 5
Chicago 4
Fuzhou 4
Guangzhou 4
Hangzhou 4
Indiana 3
London 3
Pune 3
Washington 3
Edinburgh 2
Falls Church 2
Ferrara 2
Haikou 2
Monmouth Junction 2
Taizhou 2
Tappahannock 2
Verona 2
Amsterdam 1
Barwon 1
Brampton 1
Castelbellino 1
Changchun 1
Coventry 1
Crevalcore 1
Den Haag 1
Douglas 1
Dublin 1
Florence 1
Fort Lauderdale 1
Glasgow 1
Jülich 1
Leawood 1
Marseille 1
Montreal 1
New Bedfont 1
Redwood City 1
Samarkand 1
Simi Valley 1
Singapore 1
Sucre 1
Taipei 1
Taiyuan 1
Tampa 1
Wuhan 1
Zhongxin 1
Totale 3.002
Salva come PNG Salva come JPEG
Nome #
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 133
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 119
Alteration of A3 adenosine receptors in human neutrophils and low frequency electromagnetic fields 116
A3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical study 115
A convenient synthesis by microwave heating and pharmacological evaluation of novel benzoyltriazole and saccharine derivatives as 5-HT(1A) receptor ligands 113
Effects of doxazosin and propranolol on A2A adenosine receptors in essential hypertension 111
Synthesis, radiolabeling, and preliminary biological evaluation of [H-3]-1-[(S)-N,O-bis-(isoquinolinesulfonyl)-N-methyl-tyrosyl]-4-(o-tolyl )-piperazine, a potent antagonist radioligand for the P2X(7) receptor 111
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 109
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 109
Changes of peripheral A2A adenosine receptors in chronic heart failure and cardiac transplantation 108
Expression of A3 adenosine receptors in human lymphocytes: up-regulation in T cell activation 108
Synthesis by microwave irradiation and binding properties of novel 5-HT(1A) receptor ligands 107
null 106
Expression, pharmacological profile and functional coupling of A2B receptors in a recombinant system and in peripheral blood cells by using a novel selective antagonist radioligand, [3H]MRE2029F20. 104
Pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375 cell line 103
Pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375 cell line. 102
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 101
A3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: A pharmacological and biochemical study. 101
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 100
Biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptors 94
Pyrazolotriazolopyrimidine derivatives sensitize melanoma cells to the chemiotherapic drugs: taxol and vindesine. 90
null 90
Aberrant A2A receptor function in peripheral blood cells in Huntington's disease 90
Differential expression of A3 adenosine receptors in colorectal cancer and related mucosa: a mirror in blood cells. 87
null 87
Effect of low frequency electromagnetic fields on A2A and A3 adenosine receptors in human neutrophils 85
[3H]-MRE 2029-F20, a novel selective antagonist radioligand, for the pharmacological and biochemical characterization of A2B receptors. 84
Expression and functionality of adenosine receptors in human blood cells 83
[3H]MRE2029F20 a new selective antagonist radioligand for the human A2B adenosine receptors. 82
A3 adenosine receptors in human neutrophils and promyelocitic HL60 cells: a pharmacological and biochemical study. 82
Adenosine receptors in colon carcinoma tissues and colon tumoral cell lines: focus on the A3 adenosine receptors. 77
A3 adenosine receptors in human neutrophils and promyelocitic HL60 cells: a pharmacological and biochemical study. 71
[3H]-MRE 2029-F20, A Novel Selective Antagonist Radiolig and, for the Pharmacological and Biochemical Characterization of A2B Receptors. 71
Binding and functional parameters of A2A adenosine receptors in essential hypertensive patients before and after pharmacological treatment 67
Effect of low frequency electromagnetic fields on A2A and A3 adenosine receptors in human neutrophils 66
Effect of chronic caffeine intake on A2A adenosine receptors in human neutrophils. 65
Expression, pharmacological profile, and functional coupling of A(2B) receptors in a recombinant system and in peripheral blood cells using a novel selective antagonist radioligand, [H-3]MRE 2029-F20 64
Effect of low frequency electromagnetic fields on A2A and A3 adenosine receptors in human neutrophils. 64
Effect of low frequency electromagnetic fields on A2A and A3 adenosine receptors in human neutrophils 62
Expression and functional A3 adenosine receptors in human lymphocytes 61
Effects of doxazosin and propranolol on A2A adenosine receptos of essential hypertensive patients 61
Effect of chronic caffeine intake on A2A adenosine receptors in human neutrophils. 60
Expression of functional A3 adenosine receptors in human lymphocytes: up-regulation in T cell activation. 60
Pharmacological and biochemical characterization of A3 adenosine receptors in human neutrophils and promyelocitic HL60 cells. 60
Aberrant A2A adenosine receptor function in peripheral blood cells of Huntington's disease patients and at risk mutation carriers. 59
Caffeine intake induces an alteration in human neutrophil A2A adenosine receptors 31
Adenosine Receptors in Colon Carcinoma Tissues and Colon Tumoral Cell Lines: Focus on the A3 Adenosine Subtype 25
Elevated expression of A3 adenosine receptors in human colorectal cancer is reflected in peripheral blood cells. 18
Totale 4.072
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.513
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 197
Totale 12.710
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019307 0 0 0 0 0 0 0 0 0 0 115 192
2019/2020906 159 25 20 119 54 112 75 94 83 98 54 13
2020/2021496 62 46 11 55 20 76 7 61 6 59 68 25
2021/2022477 9 51 36 16 13 17 10 16 19 37 56 197
2022/2023608 48 71 19 79 130 70 32 47 62 2 28 20
2023/2024198 24 22 9 7 33 65 7 10 8 4 9 0
Totale 4.072